Search
15 studies match these filters. Showing 1–15 of 15 studies
| Registration number | Study | Status | Phase | Enrolment | Sites / countries | Start year | Last updated | Actions |
|---|---|---|---|---|---|---|---|---|
| NCT06915233 | A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle The objective of this study is to demonstrate the superiority of MACI (autologous cultured chondrocytes on porcine collagen membrane) versus Bone Marrow Stimulation in the treatment of patients aged 17 to 65 years with symptomatic articular chondral or osteochondral defects of the talus. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 7 sites in total · contact listed | Recruiting | Phase 3 | 309target | 7 / 1 | 2026 | Jul 23, 2026 | |
| NCT06393374 | Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012) This is a randomized, open-label study comparing the efficacy and safety of adjuvant sacituzumab tirumotecan (MK-2870) in combination with pembrolizumab compared to treatment of physician's choice (TPC) in participants with triple-negative breast cancer (TNBC) who received neoadjuvant therapy and di… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 311 sites in total | Recruiting | Phase 3 | 1,530target | 311 / 31 | 2024 | Sep 17, 2026 | |
| NCT05633654 | Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63) The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 372 sites in total | Recruiting | Phase 3 | 1,514target | 372 / 11 | 2022 | Sep 9, 2026 | |
| NCT06492616 | A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast cancer with high risk of recurrence. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 567 sites in total · contact listed | Recruiting | Phase 3 | 4,220target | 567 / 28 | 2024 | Sep 15, 2026 | |
| NCT05827081 | Phase IIIb Study of Ribociclib + ET in Early Breast Cancer The purpose of this open-label, multicenter, phase IIIb, single-arm study is to characterize the efficacy and safety of the combination of ribociclib and standard adjuvant endocrine therapy (ET) on invasive breast cancer-free survival (iBCFS), in a close to clinical practice patient population with… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 229 sites in total · contact listed | Recruiting | Phase 3 | 1,400target | 229 / 16 | 2024 | Sep 18, 2026 | |
| NCT04852887 | De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA) This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 832 sites in total · contact listed | Recruiting | Phase 3 | 1,670target | 832 / 4 | 2021 | Apr 23, 2026 | |
| NCT06982521 | Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer This is a global, multicenter, open-label, randomized Phase 3 study comparing the efficacy and safety of RLY-2608 (zovegalisib) + fulvestrant to capivasertib + fulvestrant for the treatment of patients with HR+/HER2- ABC with PIK3CA mutation following recurrence or progression on or after treatment… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 231 sites in total | Recruiting | Phase 3 | 540target | 231 / 24 | 2025 | Sep 3, 2026 | |
| NCT05268289 | Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V The overall purpose of this two-part study is to evaluate the efficacy, safety and tolerability of iptacopan (LNP023) in addition to standard of care treatment. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 103 sites in total · contact listed | Recruiting | Phase 2 | 240target | 103 / 20 | 2022 | Jul 30, 2026 | |
| NCT05862272 | A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis The purpose of this clinical trial to characterize changes in bone mineral density during continuous treatment with relugolix combination tablet for up to 48 months (4 years) and 1 year of post-treatment follow-up in premenopausal women with heavy menstrual bleeding associated with uterine leiomyoma… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 120 sites in total | Recruiting | Phase 3 | 1,000target | 120 / 1 | 2023 | Aug 6, 2025 | |
| NCT06581328 | A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting Ulcerative Colitis (UC) and Crohn's Disease (CD) are long-term conditions in the gut that can cause diarrhea, swelling (inflammation), bleeding from the anus, and belly pain. The main aim of this study is to check for how many participants with UC and CD signs and symptoms disappear after 3.5 months… ✓ Contact✗ Claimed Nearest site: Hutchinson, Kansas, United States — 36 km away · 101 sites in total · contact listed | Recruiting | Phase 4 | 200target | 101 / 1 | 2025 | Sep 15, 2026 | |
| NCT06571669 | BOOM-IBD2 Pivotal Clinical Trial Ulcerative colitis is a long-lasting condition that causes swelling and sores in the large intestine. This study tests whether a small device placed under the skin can help reduce bowel urgency in people with ulcerative colitis. The investigational device sends mild signals to a nerve near the tailb… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 19 sites in total · contact listed | Recruiting | Not applicable | 137target | 19 / 1 | 2025 | Aug 6, 2026 | |
| NCT04553770 | Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer This phase II trial investigates how well trastuzumab deruxtecan works alone or in combination with anastrozole in treating patients with HER2 low, hormone receptor positive breast cancer. Trastuzumab deruxtecan is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug called derux… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 9 sites in total · contact listed | Recruiting | Phase 2 | 88target | 9 / 1 | 2020 | Nov 10, 2025 | |
| NCT07629440 | A Study to Learn About How a New Pneumococcal Vaccine Works in Infants. The purpose of this study is to learn about the safety of a new pneumococcal vaccine and how the new pneumococcal vaccine helps to fight against germs that can cause pneumonia (lung infections), meningitis (brain infections), and otitis media (ear infections) in infants when compared to the pneumoco… ✓ Contact✗ Claimed Nearest site: Derby, Kansas, United States — 54 km away · 124 sites in total | Recruiting | Phase 3 | 3,230target | 124 / 3 | 2026 | Sep 8, 2026 | |
| NCT02402244 | Project: Every Child for Younger Patients With Cancer This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 279 sites in total · contact listed | Recruiting | 75,000target | 279 / 6 | 2015 | Aug 25, 2026 | ||
| NCT05334069 | Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 745 sites in total · contact listed | Recruiting | 2,000target | 745 / 1 | 2022 | Sep 2, 2026 |